International Journal of Homoeopathic Sciences
  • Printed Journal
  • Indexed Journal
  • Refereed Journal
  • Peer Reviewed Journal
International Journal of Homoeopathic Sciences

International Journal of Homoeopathic Sciences

2022, Vol. 6 Issue 4, Part G
Effectiveness of individualised homoeopathic medicines versus Calcarea Flourica 6x in the treatment of osteoarthritis: An open-label, randomised, pragmatic clinical trial
Author(s): Dr. Tanya Rai and Dr. Arpan Bhanja
Abstract:
Background: Osteoarthritis is characterized by the destruction of joint cartilage. As the cartilage deteriorates, the bones of the joint begin to push against each other, causing pain and stiffness, often hindering or limiting movement. The joints which bear most of the weight of body is affected by osteoarthritis such as hip, knee, vertebra, and hand, it is a disease of cartilage in which interleukin play an important role.
Materials and methods: This prospective, open label, randomized controlled trial was conducted at Govt. Medical Homeopathic College, Bhopal, and Madhya Pradesh over a period of one year. A total of 60 patients with Osteoarthritis were randomized to receive Individualised Homoeopathic medicine (IH) or Calcarea Flourica 6X (CF) and outcome assessment was done using Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) & Numerical Rating Scale (NRS) scales.
Result: Our study observed that WOMAC score at baseline, there was no significant difference in WOMAC score between IH and CF group (76.23±3.90 vs. 76.06±3.70; p = 0.866).
Conclusion: Both Individualized homeopathic treatment as well as Calcarea Fluor are effective in reducing pain and functional outcomes in patients with osteoarthritis. However, individualized homeopathic treatment provided a better efficacy than Calcarea Fluor.
Pages: 417-424  |  242 Views  99 Downloads
Download Full Article: Click Here
How to cite this article:
Dr. Tanya Rai, Dr. Arpan Bhanja. Effectiveness of individualised homoeopathic medicines versus Calcarea Flourica 6x in the treatment of osteoarthritis: An open-label, randomised, pragmatic clinical trial. Int J Hom Sci 2022;6(4):417-424. DOI: 10.33545/26164485.2022.v6.i4g.690
International Journal of Homoeopathic Sciences
Call for book chapter